13-May-2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, DRQ, FUSN
PRNewswire (Fri, 10-May 1:51 PM ET)
TipRanks (Fri, 10-May 2:02 AM ET)
Catalent’s Resilient Growth and Positive Outlook Reinforce Buy Rating
TipRanks (Fri, 10-May 1:41 AM ET)
RBC Capital Sticks to Their Hold Rating for Catalent (CTLT)
TipRanks (Thu, 9-May 6:49 AM ET)
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
Business Wire (Wed, 8-May 4:15 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, HRT, CTLT
Globe Newswire (Sat, 4-May 9:18 AM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SWAV, MODN
PRNewswire (Thu, 2-May 12:35 PM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, ANSS, CTLT
PRNewswire (Mon, 29-Apr 10:40 PM ET)
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates CTLT, CRC, HRT
Globe Newswire (Sat, 27-Apr 8:51 AM ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCP, NXPL, CTLT
Globe Newswire (Fri, 26-Apr 8:56 AM ET)
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Catalent trades on the NYSE stock market under the symbol CTLT.
As of May 13, 2024, CTLT stock price declined to $55.80 with 1,327,150 million shares trading.
CTLT has a beta of 1.35, meaning it tends to be more sensitive to market movements. CTLT has a correlation of 0.09 to the broad based SPY ETF.
CTLT has a market cap of $10.10 billion. This is considered a Large Cap stock.
Last quarter Catalent reported $1 billion in Revenue and -$.06 earnings per share. This fell short of revenue expectation by $-46 million and missed earnings estimates by -$.27.
In the last 3 years, CTLT stock traded as high as $142.64 and as low as $31.45.
The top ETF exchange traded funds that CTLT belongs to (by Net Assets): VTI, VOO, VB, SPY, RSP.
CTLT has outperformed the market in the last year with a return of +69.8%, while the SPY ETF gained +28.2%. However, in the most recent history, CTLT shares have underperformed the stock market with its stock returning -0.8% in the last 3 month period and -0.9% for the last 2 week period, while SPY has returned +5.8% and +2.1%, respectively.
CTLT support price is $55.45 and resistance is $56.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTLT stock will trade within this expected range on the day.